Robert P. Garen: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Letters

Claire Bonney, Nancy Shatzman Steinhardt, Jerrilynn D. Dodds, Sally Garen, Richard A. Plunz and Robert Bruegmann

Journal:

Journal of the Society of Architectural Historians

Year:

1992

Language:

english

File:

PDF, 1.22 MB

english, 1992

2

Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial

Carlos A. Molina, Andrew D. Barreto, Georgios Tsivgoulis, Paul Sierzenski, Marc D. Malkoff, Marta Rubiera, Nicole Gonzales, Robert Mikulik, Greg Pate, James Ostrem, Walter Singleton, Garen Manvelian,

Journal:

Annals of Neurology

Year:

2009

Language:

english

File:

PDF, 730 KB

english, 2009

3

10.1038/77950

Ng, Kenneth K.S., Petersen, Jens F.W., Cherney, Maia M., Garen, Craig, Zalatoris, Jeffrey J., Rao-Naik, Chetana, Dunn, Ben M., Martzen, Mark R., Peanasky, Robert J., James, Michael N.G.

Journal:

Natural Structural Biology

Year:

2000

Language:

english

File:

PDF, 552 KB

english, 2000

4

Lack of an EMF-induced genotoxic effect in the ames assay

Melissa A. Morandi, Cindy M. Pak, Robert P. Garen, Linda D. Caren

Journal:

Year:

1996

Language:

english

File:

PDF, 649 KB

english, 1996

5

Comparison of growth of mussel, Mytilus edulis, on longline, pole and bottom culture sites in the Pertuis Breton, France

P Garen, S Robert, S Bougrier

Journal:

Year:

2004

Language:

english

File:

PDF, 325 KB

english, 2004

6

Adipose tissue NK cells manifest an activated phenotype in human obesity

O’Rourke, Robert W., Gaston, Garen D., Meyer, Kevin A., White, Ashley E., Marks, Daniel L.

Journal:

Year:

2013

Language:

english

File:

PDF, 722 KB

english, 2013

7

Suppressor genes for nonsense mutations

Garen, Alan, Garen, Suzanne, Wilhelm, Robert C.

Journal:

Journal of Molecular Biology

Year:

1965

Language:

english

File:

PDF, 778 KB

english, 1965

8

Systemic NK cell ablation attenuates intra-abdominal adipose tissue macrophage infiltration in murine obesity

O'Rourke, Robert W., Meyer, Kevin A., Neeley, Christopher K., Gaston, Garen D., Sekhri, Palak, Szumowski, Marek, Zamarron, Brian, Lumeng, Carey N., Marks, Daniel L.

Journal:

Year:

2014

Language:

english

File:

PDF, 378 KB

english, 2014

9

Institutional Investors and Insider Trading Profitability

Bricker, Robert, Markarian, Garen

Journal:

European Accounting Review

Year:

2015

Language:

english

File:

PDF, 485 KB

english, 2015

10

Development and Content Validity Testing of a Patient-Reported Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

Tatlock, Sophi, Grant, Laura, Spertus, John A., Khan, Irfan, Arbuckle, Rob, Manvelian, Garen, Sanchez, Robert J.

Journal:

Value in Health

Year:

2015

Language:

english

File:

PDF, 948 KB

english, 2015

11

Psychometric Evaluation of a Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

Tatlock, Sophi, Arbuckle, Rob, Sanchez, Robert, Grant, Laura, Khan, Irfan, Manvelian, Garen, Spertus, John A.

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 1.60 MB

english, 2017

12

ALIROCUMAB TITRATION STRATEGY ALLOWS INDIVIDUALIZED LDL-C REDUCTION IN A REAL WORLD SETTING: RESULTS FROM ODYSSEY OLE (LONG TERM COHORT)

Dufour, Robert, Hovingh, G. Kees, Guyton, John, Langslet, Gisle, Baccara-Dinet, Marie, Din-Bell, Chantal, Manvelian, Garen, Farnier, Michel

Journal:

Journal of the American College of Cardiology

Year:

2017

Language:

english

File:

PDF, 346 KB

english, 2017

13

ON-TREATMENT LDL-C LEVELS WHEN ALIROCUMAB DOSE IS DECREASED FROM 150 TO 75 MG EVERY 2 WEEKS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM ODYSSEY OLE

Farnier, Michel, Guyton, John, Langslet, Gisle, Dufour, Robert, Baccara-Dinet, Marie, Din-Bell, Chantal, Manvelian, Garen, Hovingh, G. Kees

Journal:

Journal of the American College of Cardiology

Year:

2017

Language:

english

File:

PDF, 344 KB

english, 2017

14

ALIROCUMAB TREATMENT IN A REAL WORLD SETTING: SAFETY UPDATE FROM AN OPEN-LABEL TREATMENT EXTENSION TO THE ODYSSEY PROGRAM FOR PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

Guyton, John R., Hovingh, G. Kees, Langslet, Gisle, Dufour, Robert, Baccara-Dinet, Marie, Din-Bell, Chantal, Manvelian, Garen, Farnier, Michel

Journal:

Journal of the American College of Cardiology

Year:

2017

Language:

english

File:

PDF, 351 KB

english, 2017

15

The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability

Rosenson, Robert S, Miller, Kate, Bayliss, Martha, Sanchez, Robert J, Baccara-Dinet, Marie T, Chibedi-De-Roche, Daniela, Taylor, Beth, Khan, Irfan, Manvelian, Garen, White, Michelle, Jacobson, Terry A

Journal:

Cardiovascular Drugs and Therapy

Year:

2017

Language:

english

File:

PDF, 989 KB

english, 2017

16

Durability of Alirocumab Effect: Data From an Open-Label Extension to the ODYSSEY Program for Patients With Heterozygous Familial Hypercholesterolemia

Farnier, Michel, Hovingh, G Kees, Langslet, Gisle, Dufour, Robert, Baccara-Dinet, Marie, Din-Bell, Chantal, Manvelian, Garen, Guyton, John

Journal:

Journal of Clinical Lipidology

Year:

2017

Language:

english

File:

PDF, 85 KB

english, 2017

17

Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Randomized Trial on Statin Myopathy

Taylor, Beth A., Sanchez, Robert J., Jacobson, Terry A., Chibedi-De-Roche, Daniela, Manvelian, Garen, Baccara-Dinet, Marie T., Khan, Irfan, Rosenson, Robert S.

Journal:

Journal of the American College of Cardiology

Year:

2017

Language:

english

File:

PDF, 133 KB

english, 2017

18

Hexosamine Biosynthesis Is a Possible Mechanism Underlying Hypoxia’s Effects on Lipid Metabolism in Human Adipocytes

O’Rourke, Robert W., Meyer, Kevin A., Gaston, Garen, White, Ashley E., Lumeng, Carey N., Marks, Daniel L., Taylor, Cormac T.

Journal:

Year:

2013

Language:

english

File:

PDF, 1.17 MB

english, 2013

19

Institutional Investors and Insider Trading Profitability

Bricker, Robert J., Markarian, Garen

Journal:

SSRN Electronic Journal

Year:

2008

Language:

english

File:

PDF, 455 KB

english, 2008

20

Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program

Farnier, Michel, Hovingh, G. Kees, Langslet, Gisle, Dufour, Robert, Baccara-Dinet, Marie T., Din-Bell, Chantal, Manvelian, Garen, Guyton, John R.

Journal:

Atherosclerosis

Year:

2018

Language:

english

File:

PDF, 2.04 MB

english, 2018

21

Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia

Hovingh, G. Kees, Guyton, John R., Langslet, Gisle, Dufour, Robert, Baccara-Dinet, Marie T., Din-Bell, Chantal, Manvelian, Garen, Farnier, Michel

Journal:

Journal of Clinical Lipidology

Year:

2018

Language:

english

File:

PDF, 439 KB

english, 2018

22

Role of Tissue Factor in Metastasis: Functions of the Cytoplasmic and Extracellular Domains of the Molecule

Bromberg, Michael, Sundaram, Ranjini, Homer, Robert, Garen, Alan, Konigsberg, William

Journal:

Thrombosis and Haemostasis

Year:

1999

Language:

english

File:

PDF, 206 KB

english, 1999

23

Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial

Dufour, Robert, Hovingh, G. Kees, Guyton, John R., Langslet, Gisle, Baccara-Dinet, Marie T., Din-Bell, Chantal, Manvelian, Garen, Farnier, Michel

Journal:

Journal of Clinical Lipidology

Year:

2018

Language:

english

File:

PDF, 1.18 MB

english, 2018